ARCT
Price
$21.92
Change
+$1.44 (+7.03%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
556.12M
34 days until earnings call
FDMT
Price
$8.68
Change
-$0.05 (-0.57%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
407.71M
34 days until earnings call
Interact to see
Advertisement

ARCT vs FDMT

Header iconARCT vs FDMT Comparison
Open Charts ARCT vs FDMTBanner chart's image
Arcturus Therapeutics Holdings
Price$21.92
Change+$1.44 (+7.03%)
Volume$7.56K
Capitalization556.12M
4D Molecular Therapeutics
Price$8.68
Change-$0.05 (-0.57%)
Volume$4.63K
Capitalization407.71M
ARCT vs FDMT Comparison Chart in %
Loading...
ARCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FDMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARCT vs. FDMT commentary
Oct 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARCT is a Hold and FDMT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 03, 2025
Stock price -- (ARCT: $20.48 vs. FDMT: $8.73)
Brand notoriety: ARCT and FDMT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARCT: 169% vs. FDMT: 41%
Market capitalization -- ARCT: $556.12M vs. FDMT: $407.71M
ARCT [@Biotechnology] is valued at $556.12M. FDMT’s [@Biotechnology] market capitalization is $407.71M. The market cap for tickers in the [@Biotechnology] industry ranges from $103.64B to $0. The average market capitalization across the [@Biotechnology] industry is $1.98B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARCT’s FA Score shows that 0 FA rating(s) are green whileFDMT’s FA Score has 0 green FA rating(s).

  • ARCT’s FA Score: 0 green, 5 red.
  • FDMT’s FA Score: 0 green, 5 red.
According to our system of comparison, ARCT is a better buy in the long-term than FDMT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARCT’s TA Score shows that 3 TA indicator(s) are bullish while FDMT’s TA Score has 4 bullish TA indicator(s).

  • ARCT’s TA Score: 3 bullish, 5 bearish.
  • FDMT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, FDMT is a better buy in the short-term than ARCT.

Price Growth

ARCT (@Biotechnology) experienced а +1.09% price change this week, while FDMT (@Biotechnology) price change was +3.44% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.18%. For the same industry, the average monthly price growth was +13.86%, and the average quarterly price growth was +79.28%.

Reported Earning Dates

ARCT is expected to report earnings on Nov 05, 2025.

FDMT is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+5.18% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARCT($556M) has a higher market cap than FDMT($408M). FDMT YTD gains are higher at: 56.732 vs. ARCT (20.684). ARCT has higher annual earnings (EBITDA): -54.54M vs. FDMT (-213.2M). FDMT has more cash in the bank: 293M vs. ARCT (196M). FDMT has less debt than ARCT: FDMT (23.1M) vs ARCT (27M). ARCT has higher revenues than FDMT: ARCT (110M) vs FDMT (33K).
ARCTFDMTARCT / FDMT
Capitalization556M408M136%
EBITDA-54.54M-213.2M26%
Gain YTD20.68456.73236%
P/E RatioN/AN/A-
Revenue110M33K333,333%
Total Cash196M293M67%
Total Debt27M23.1M117%
FUNDAMENTALS RATINGS
ARCT: Fundamental Ratings
ARCT
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
43
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
37

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARCTFDMT
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
74%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 11 days ago
80%
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
79%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
ARCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FDMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TISPX73.57N/A
N/A
Nuveen S&P 500 Index R6
FGNCX12.90N/A
N/A
Nuveen Global Infrastructure C
ABYEX9.95N/A
N/A
AB Emerging Markets Multi-Asset Advisor
TRMVX28.69N/A
N/A
SEI Large Cap Value F (SIMT)
ANODX24.65N/A
N/A
American Century Small Cap Growth R6

FDMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, FDMT has been loosely correlated with LRMR. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if FDMT jumps, then LRMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FDMT
1D Price
Change %
FDMT100%
+0.46%
LRMR - FDMT
43%
Loosely correlated
+28.48%
RGNX - FDMT
42%
Loosely correlated
+1.24%
ARCT - FDMT
41%
Loosely correlated
+11.12%
IDYA - FDMT
40%
Loosely correlated
+0.55%
CLDX - FDMT
40%
Loosely correlated
-2.24%
More